Symplostatin 1: A Dolastatin 10 Analogue from the Marine Cyanobacterium Symploca hydnoides-Reference-Cited by-同舟云学术

Symplostatin 1: A Dolastatin 10 Analogue from the Marine Cyanobacterium Symploca hydnoides

Published:1998-09-01 Issue:9 Volume:61 Page:1075-1077
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Harrigan George G.¹,Luesch Hendrik¹,Yoshida Wesley Y.¹,Moore Richard E.¹,Nagle Dale G.¹,Paul Valerie J.¹,Mooberry Susan L.¹,Corbett Thomas H.¹,Valeriote Fred A.¹

Affiliation:

1. Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii 96822, University of Guam Marine Laboratory, UOG Station, Mangilao, Guam 96923, Cancer Research Center of Hawaii, 1236 Lauhala Street, Honolulu, Hawaii 96813, Karmanos Cancer Center, Wayne State University, Detroit, Michigan 48201, and Department of Internal Medicine, Wayne State University, Detroit, Michigan 48201

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/np980321c

Reference16 articles.

1. (a) Pettit, G. R.; Kamano, Y.; Herald, C. L.; Fujii, Y.; Kizu, H.; Boyd, M. R.; Boettner, F. E.; Doubek, D. L.; Schmidt, J. M.; Chapuis, J.C.; Michel, C.Tetrahedron1993,49, 9151−9170.

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads;European Journal of Medicinal Chemistry;2024-10

2. Something ‘Old, New, Borrowed, or Blue’, the Search for Mother Nature’s Bioactive Agents;Current Opinion in Biotechnology;2024-08

3. Synthesis and Late-Stage Modification of (−)-Doliculide Derivatives Using Matteson’s Homologation Approach;Marine Drugs;2024-04-08

4. Biosynthesis of Dolastatin 10 in Marine Cyanobacteria, a Prototype for Multiple Approved Cancer Drugs;Organic Letters;2024-02-08

5. Dolastatins and their analogues present a compelling landscape of potential natural and synthetic anticancer drug candidates;Current Research in Biotechnology;2024